Cytotoxic Drugs Market By Drug Type, Route of Administration and Distribution Channel- Global Industry Analysis and Forecast to 2023

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.1.1.    Growing Global Prevalence of Various Cancers

3.2.2.  Restraints

3.2.2.1.    Severe Side-Effects Related to These Drugs

3.2.3.  Opportunities

3.2.3.1.    Emerging Countries to Offer Lucrative Growth Opportunities

4.       Cytotoxic Drugs Market, By Drug Type

4.1.       Introduction

4.2.       Global Cytotoxic Drugs Sales, Revenue and Market Share by Drug Type (2017-2017)

4.2.1.  Global Cytotoxic Drugs Sales and Sales Share by Drug Type (2017-2017)

4.2.2.  Global Cytotoxic Drugs Revenue and Revenue Share by Drug Type (2017-2017)

4.3.       Cytotoxic Drugs Market   Assessment and Forecast, By Drug Type, 2017-2023

4.4.       Alkylating Agents

4.4.1.  Market Assessment and Forecast, By Region, 2017-2023($Billion)

4.5.       Antimetabolites

4.5.1.  Market Assessment and Forecast, By Region, 2017-2023($Billion)

4.6.       Vinca Alkaloids

4.6.1.  Market Assessment and Forecast, By Region, 2017-2023($Billion)

4.7.       Taxanes

4.7.1.  Market Assessment and Forecast, By Region, 2017-2023($Billion)

4.8.       Epipodophyllo Toxin

4.8.1.  Market Assessment and Forecast, By Region, 2017-2023($Billion)

4.9.       Camptothecin Analogues

4.9.1.  Market Assessment and Forecast, By Region, 2017-2023($Billion)

4.10.    Miscellaneous

4.10.1.      Market Assessment and Forecast, By Region, 2017-2023($Billion)

5.       Cytotoxic Drugs Market, By Route of Administration

5.1.       Introduction

5.2.       Global Cytotoxic Drugs Sales, Revenue and Market Share by Route of Administration (2017-2017)

5.2.1.  Global Cytotoxic Drugs Sales and Sales Share by Route of Administration (2017-2017)

5.2.2.  Global Cytotoxic Drugs Revenue and Revenue Share by Route of Administration (2017-2017)

5.3.       Cytotoxic Drugs Market   Assessment and Forecast, By Route of Administration, 2017-2023

5.4.       Oral

5.4.1.  Market Assessment and Forecast, By Region, 2017-2023($Billion)

5.5.       Intravenous

5.5.1.  Market Assessment and Forecast, By Region, 2017-2023($Billion)

6.       Cytotoxic Drugs Market, By Distribution Channel

6.1.       Introduction

6.2.       Global Cytotoxic Drugs Sales, Revenue and Market Share by Distribution Channel (2017-2017)

6.2.1.  Global Cytotoxic Drugs Sales and Sales Share by Distribution Channel (2017-2017)

6.2.2.  Global Cytotoxic Drugs Revenue and Revenue Share by Distribution Channel (2017-2017)

6.3.       Cytotoxic Drugs Market   Assessment and Forecast, By Distribution Channel, 2017-2023($Billion)

6.4.       Hospital Pharmacies

6.4.1.  Market Assessment and Forecast, By Region, 2017-2023($Billion)

6.5.       Retail Pharmacies 

6.5.1.  Market Assessment and Forecast, By Region, 2017-2023($Billion)

6.6.       Online Pharmacies

6.6.1.  Market Assessment and Forecast, By Region, 2017-2023($Billion)

7.       Cytotoxic Drugs Market, By Region

7.1.       Introduction

7.2.       Cytotoxic Drugs Market   Assessment and Forecast, By Region, 2017-2023($Billion)

7.3.       Global Cytotoxic Drugs Sales, Revenue and Market Share by Regions

7.3.1.  Global Cytotoxic Drugs Sales by Regions (2017-2017)

7.3.2.  Global Cytotoxic Drugs Revenue by Regions (2017-2017)

7.4.       North America

7.4.1.  North America Cytotoxic Drugs Sales and Growth Rate (2017-2017)

7.4.2.  Market Assessment and Forecast, By Country, 2017-2023($Billion)

7.4.3.  Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

7.4.4.  Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

7.4.5.  Market Assessment and Forecast, By Distribution Channel, 2017-2023($Billion)

7.4.6.  U.S.

7.4.6.1.1.    Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

7.4.6.1.2.    Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

7.4.6.1.3.    Market Assessment and Forecast, By Distribution Channel, 2017-2023($Billion)

7.4.6.2.    Canada

7.4.6.2.1.    Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

7.4.6.2.2.    Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

7.4.6.2.3.    Market Assessment and Forecast, By Distribution Channel, 2017-2023($Billion)

7.4.6.3.    Mexico

7.4.6.3.1.    Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

7.4.6.3.2.    Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

7.4.6.3.3.    Market Assessment and Forecast, By Distribution Channel, 2017-2023($Billion)

7.5.       Europe

7.5.1.  Europe Cytotoxic Drugs Sales and Growth Rate (2017-2017)

7.5.2.  Market Assessment and Forecast, By Country, 2017-2023($Billion)

7.5.3.  Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

7.5.4.  Market Assessment and Forecast, By Distribution Channel, 2017-2023($Billion)

7.5.5.  Market Assessment and Forecast, By Distribution Channel, 2017-2023($Billion)

7.5.6.  Germany

7.5.6.1.1.    Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

7.5.6.1.2.    Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

7.5.6.1.3.    Market Assessment and Forecast, By Distribution Channel, 2017-2023($Billion)

7.5.7.  France

7.5.7.1.1.    Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

7.5.7.1.2.    Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

7.5.7.1.3.    Market Assessment and Forecast, By Distribution Channel, 2017-2023($Billion)

7.5.8.  UK

7.5.8.1.1.    Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

7.5.8.1.2.    Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

7.5.8.1.3.    Market Assessment and Forecast, By Distribution Channel, 2017-2023($Billion)

7.5.9.  Italy

7.5.9.1.1.    Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

7.5.9.1.2.    Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

7.5.9.1.3.    Market Assessment and Forecast, By Distribution Channel, 2017-2023($Billion)

7.5.10.      Spain

7.5.10.1.1. Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

7.5.10.1.2. Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

7.5.10.1.3. Market Assessment and Forecast, By Distribution Channel, 2017-2023($Billion)

7.5.10.2. Rest of Europe

7.5.10.2.1. Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

7.5.10.2.2. Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

7.5.10.2.3. Market Assessment and Forecast, By Distribution Channel, 2017-2023($Billion)

8.       Asia-Pacific

8.1.1.  Asia-Pacific Cytotoxic Drugs Sales and Growth Rate (2017-2017)

8.1.2.  Market Assessment and Forecast, By Country, 2017-2023($Billion)

8.1.3.  Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

8.1.4.  Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

8.1.5.  Market Assessment and Forecast, By Distribution Channel,2017-2023($Billion)

8.1.5.1.    Japan

8.1.5.1.1.    Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

8.1.5.1.2.    Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

8.1.5.1.3.    Market Assessment and Forecast, By Distribution Channel,2017-2023($Billion)

8.1.6.  China

8.1.6.1.1.    Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

8.1.6.1.2.    Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

8.1.6.1.3.    Market Assessment and Forecast, By Distribution Channel,2017-2023($Billion)

8.1.7.  Australia

8.1.7.1.1.    Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

8.1.7.1.2.    Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

8.1.7.1.3.    Market Assessment and Forecast, By Distribution Channel,2017-2023($Billion)

8.1.8.  India

8.1.8.1.1.    Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

8.1.8.1.2.    Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

8.1.8.1.3.    Market Assessment and Forecast, By Distribution Channel,2017-2023($Billion)

8.1.9.  South Korea

8.1.9.1.1.    Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

8.1.9.1.2.    Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

8.1.9.1.3.    Market Assessment and Forecast, By Distribution Channel,2017-2023($Billion)

8.1.10.      Rest of Asia-Pacific

8.1.10.1.1. Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

8.1.10.1.2. Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

8.1.10.1.3. Market Assessment and Forecast, By Distribution Channel,2017-2023($Billion)

9.       Rest of the World

9.1.1.  Rest of the World Cytotoxic Drugs Sales and Growth Rate (2017-2017)

9.1.2.  Market Assessment and Forecast, By Country, 2017-2023($Billion)

9.1.3.  Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

9.1.4.  Market Assessment and Forecast, By Distribution Channel,2017-2023($Billion)

9.1.5.  Market Assessment and Forecast, By Distribution Channel,2017-2023($Billion)

9.1.6.  Brazil

9.1.6.1.1.    Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

9.1.6.1.2.    Market Assessment and Forecast, By Drug Type , 2017-2023($Billion)

9.1.6.1.3.    Market Assessment and Forecast, By Distribution Channel,2017-2023($Billion)

9.1.7.  Turkey

9.1.7.1.1.    Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

9.1.7.1.2.    Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

9.1.7.1.3.    Market Assessment and Forecast, By Distribution Channel,2017-2023($Billion)

9.1.8.  Saudi Arabia

9.1.8.1.1.    Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

9.1.8.1.2.    Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

9.1.8.1.3.    Market Assessment and Forecast, By Distribution Channel,2017-2023($Billion)

9.1.9.  South Africa

9.1.9.1.1.    Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

9.1.9.1.2.    Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

9.1.9.1.3.    Market Assessment and Forecast, By Distribution Channel,2017-2023($Billion)

9.1.10.      United Arab Emirates

9.1.10.1.1. Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

9.1.10.1.2. Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

9.1.10.1.3. Market Assessment and Forecast, By Distribution Channel,2017-2023($Billion)

9.1.11.      Others

9.1.11.1.1. Market Assessment and Forecast, By Route of Administration, 2017-2023($Billion)

9.1.11.1.2. Market Assessment and Forecast, By Drug Type, 2017-2023($Billion)

9.1.11.1.3. Market Assessment and Forecast, By Distribution Channel,2017-2023($Billion)

10.   Company Profiles

10.1.      Eli Lilly and Company 

10.1.1.      Business Overview

10.1.2.      Product Portfolio

10.1.3.      Strategic Developments

10.1.4.      Cytotoxic Drugs Sales, Revenue and Market Share

10.2.    Roche Diagnostics

10.2.1.      Business Overview

10.2.2.      Product Portfolio

10.2.3.      Strategic Developments

10.2.4.      Cytotoxic Drugs Sales, Revenue and Market Share

10.3.    Pfizer

10.3.1.      Business Overview

10.3.2.      Product Portfolio

10.3.3.      Strategic Developments

10.3.4.      Cytotoxic Drugs Sales, Revenue and Market Share

10.4.    Sanofi

10.4.1.      Business Overview

10.4.2.      Product Portfolio

10.4.3.      Strategic Developments

10.4.4.      Cytotoxic Drugs Sales, Revenue and Market Share

10.5.    Amgen Inc.

10.5.1.      Business Overview

10.5.2.      Product Portfolio

10.5.3.      Strategic Developments

10.5.4.      Cytotoxic Drugs Sales, Revenue and Market Share

10.6.    Celgene Corporation

10.6.1.      Business Overview

10.6.2.      Product Portfolio

10.6.3.      Strategic Developments

10.6.4.      Cytotoxic Drugs Sales, Revenue and Market Share

10.7.     Novartis AG

10.7.1.      Business Overview

10.7.2.      Product Portfolio

10.7.3.      Strategic Developments

10.7.4.      Cytotoxic Drugs Sales, Revenue and Market Share

10.8.    GlaxoSmithKline PLC

10.8.1.      Business Overview

10.8.2.      Product Portfolio

10.8.3.      Strategic Developments

10.8.4.      Cytotoxic Drugs Sales, Revenue and Market Share

10.9.    Merck & Company

10.9.1.      Business Overview

10.9.2.      Product Portfolio

10.9.3.      Strategic Developments

10.9.4.      Cytotoxic Drugs Sales, Revenue and Market Share

10.10.Johnson and Johnson

10.10.1.  Business Overview

10.10.2.  Product Portfolio

10.10.3.  Strategic Developments

10.10.4.  Cytotoxic Drugs Sales, Revenue and Market Share

11.   Global Cytotoxic Drugs Market Competition, by Manufacturer

11.1.    Global Cytotoxic Drugs Sales and Market Share by Manufacturer (2017-2017)

11.2.    Global Cytotoxic Drugs Revenue and Market Share by Manufacturer (2017-2017)

11.3.    Top 5 Cytotoxic Drugs Manufacturer Market Share

11.4.    Market Competition Trend

---

List of Tables

List of Tables

Table: Global Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Global Cytotoxic Drugs Sales and Sales Share by Drug Type (2017-2017)

Table: Global Cytotoxic Drugs Revenue and Revenue Share by Drug Type (2017-2017)

Table: Alkylating Agents Market, By Region, 2017-2023($Million)

Table: Antimetabolites Market, By Region, 2017-2023($Million)

Table: Vinca Alkaloids Market, By Region, 2017-2023($Million)

Table: Taxanes Market, By Region, 2017-2023($Million)

Table: Epipodophyllo Toxin Market, By Region, 2017-2023($Million)

Table: Camptothecin Analogues Market, By Region, 2017-2023($Million)

Table: Miscellaneous Market, By Region, 2017-2023($Million)



Table: Global Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: Global Cytotoxic Drugs Sales and Sales Share by Route of Administration (2017-2017)

Table: Global Cytotoxic Drugs Revenue and Revenue Share by Route of Administration (2017-2017)

Table: Oral Market, By Region, 2017-2023($Million)

Table: Intravenous Market, By Region, 2017-2023($Million)

Table: Global Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Global Cytotoxic Drugs Sales and Sales Share by Distribution Channel (2017-2017)

Table: Global Cytotoxic Drugs Revenue and Revenue Share by Distribution Channel (2017-2017)

Table: Hospital Pharmacies Market, By Region, 2017-2023($Million)

Table: Retail Pharmacies Market, By Region, 2017-2023($Million)

Table: Online Pharmacies Market, By Region, 2017-2023($Million)

Table: Global Cytotoxic Drugs Sales, Revenue and Market Share by Regions

Table: North America Cytotoxic Drugs Sales and Growth Rate (2017-2017)

Table: North America Cytotoxic Drugs Market, By Country, 2017-2023($Million)

Table: North America Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: North America Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: North America Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: U.S. Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: U.S. Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: U.S. Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Canada Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: Canada Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Canada Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Mexico Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: Mexico Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Mexico Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Europe Cytotoxic Drugs Sales and Growth Rate (2017-2017)

Table: Europe Cytotoxic Drugs Market, By Country, 2017-2023($Million)

Table: Europe Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: Europe Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Europe Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Germany Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: Germany Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Germany Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: France Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: France Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: France Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: UK Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: UK Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: UK Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Italy Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: Italy Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Italy Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Spain Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: Spain Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Spain Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Rest of Europe Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: Rest of Europe Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Rest of Europe Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Asia-Pacific Cytotoxic Drugs Sales and Growth Rate (2017-2017)

Table: Asia-Pacific Cytotoxic Drugs Market, By Country, 2017-2023($Million)

Table: Asia-Pacific Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: Asia-Pacific Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Asia-Pacific Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Japan Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: Japan Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Japan Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: China Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: China Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: China Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Australia Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: Australia Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Australia Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: India Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: India Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: India Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: South Korea Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: South Korea Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: South Korea Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Rest of Asia-Pacific Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: Rest of Asia-Pacific Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Rest of Asia-Pacific Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Rest of the World Cytotoxic Drugs Sales and Growth Rate (2017-2017)

Table: Rest of the World Cytotoxic Drugs Market, By Country, 2017-2023($Million)

Table: Rest of the World Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: rest of the World Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Rest of the World Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Brazil Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: Brazil Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Brazil Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Turkey Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: Turkey Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Turkey Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Saudi Arabia Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: Saudi Arabia Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Saudi Arabia Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: South Africa Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: South Africa Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: South Africa Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: United Arab Emirates Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: United Arab Emirates Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: United Arab Emirates Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Others Cytotoxic Drugs Market, By Route of Administration, 2017-2023($Million)

Table: Others Cytotoxic Drugs Market, By Drug Type, 2017-2023($Million)

Table: Others Cytotoxic Drugs Market, By Distribution Channel, 2017-2023($Million)

Table: Eli Lilly and Company: Key Strategic Developments, 2017-2017

Table: Roche Diagnostics: Key Strategic Developments, 2017-2017

Table: Pfizer: Key Strategic Developments, 2017-2017

Table: Sanofi: Key Strategic Developments, 2017-2017

Table: Amgen Inc.: Key Strategic Developments, 2017-2017

Table: Celgene Corporation: Key Strategic Developments, 2017-2017

Table: Novartis AG: Key Strategic Developments, 2017-2017

Table: GlaxoSmithKline PLC: Key Strategic Developments, 2017-2017

Table: Merck & Company: Key Strategic Developments, 2017-2017

Table: Johnson and Johnson: Key Strategic Developments, 2017-2017

---

List of Figures

Figure: Global Cytotoxic Drugs Market Share, By Drug Type, 2017 & 2023

Figure: Global Cytotoxic Drugs Market, By Route of Administration, 2017 & 2023 ($Million)

Figure: Global Cytotoxic Drugs Market, By Distribution Channel, 2017 & 2023 ($Million)

Figure: Global Cytotoxic Drugs Market, By Region, 2017 & 2023 ($Million)

Figure: Global Cytotoxic Drugs Sales and Sales Share by Drug Type (2017-2017)

Figure: Global Cytotoxic Drugs Revenue and Revenue Share by Drug Type (2017-2017)

Figure: Global Cytotoxic Drugs Sales and Sales Share by Route of Administration (2017-2017)

Figure: Global Cytotoxic Drugs Revenue and Revenue Share by Route of Administration (2017-2017)

Figure: Global Cytotoxic Drugs Sales and Sales Share by Distribution Channel (2017-2017)

Figure: Global Cytotoxic Drugs Revenue and Revenue Share by Distribution Channel (2017-2017)

Figure: North America Cytotoxic Drugs Sales and Growth Rate (2017-2017)

Figure: Europe Cytotoxic Drugs Sales and Growth Rate (2017-2017)

Figure: Asia-Pacific Cytotoxic Drugs Sales and Growth Rate (2017-2017)

Figure: Rest of the World Cytotoxic Drugs Sales and Growth Rate (2017-2017)

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

• Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

• Number of patients for particular device or medical procedure and
• Repeated use of particular device depending on health and condition of patient

• Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country